[Tickers Inside] 6 Solid Gainers Over the Last 5 Sessions

Stocks with 5 days of consecutive price advances. If you cannot see this email properly, please click [here]( [9k=] --------------------------------------------------------------- [Biden Executive Order 14017 Potentially Sending Lithium Stocks Skyrocketing]( [See How Order 14017 Could Send This Company Skyrocketing]([aff_i?offer_...] --------------------------------------------------------------- September 16, 2022 From the desk of the Editor (5 Day Gainers Report) Dear Reader, We just identified 6 Five Day Gainers of all US Exchanges. If you are interested in any of these companies, we encourage you to do your own research and due diligence. Keep reading to see what we just uncovered... --------------------------------------------------------------- ["The Most Critical Metal for Global Economies"]( [e33a456c-e65...](The soaring demand for this "red rock" may be the most important development in 2022. It's key in the transition to the new green energy economies. Bloomberg News warns… "Within a decade, the world may face a massive shortfall of what's arguably the most critical metal for global economies." Copper prices have nearly doubled in the past year. [Find Out How This Is Good News for Commodity Investors.]( //trailer.web-view.net/Links/0X0595CAAEAFB89E2E510DD6C962187FA852E761478D41CDAFAEAAA68CA6015EB0D958CCFD3AB4C59C4172733E16BFD56086F4752F34D7E0BB97B78C110EC8F65BF598CD369566B7DD.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Arqit Quantum, ARQQ]( Recent Analyst Action: Jamie Shelton, analyst at Deutsche Bank, reiterates coverage on [Arqit Quantum (ARQQ)](in the Technology sector with a Hold rating and a price target of $7.00 (1 month ago). - Recent Price: $8.22 - Average Analyst Price Target: $7.00 (-14.84%) - Market Cap: $1.04B [TipRanks.com]( also reports that [Arqit Quantum](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $7.00. The target pricing ranges from a high forecast of $7.00 down to a low forecast of $7.00. [Arqit Quantum (ARQQ)](’s last closing price was $8.22 which would put the average price target at $7.00. Here are 3rd party ratings for [ARQQ](: - TipRanks.com: Hold - TradingView.com: Neutral - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Hold, Bottom 41% (148 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Top 5 Cheap Stocks to Own Right Now]( While finding safe stocks with the potential for monster gains isn't always easy, we've found a few that could pay out well. In fact, within our report, ["Top 5 Cheap Stock to Own Right Now"](, we have identified five stocks we believe could appreciate the most even if you just have $1,000 to invest. [Sign up here to get your free report now.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [InnovAge Holding, INNV]( Recent Analyst Action: Sarah James, analyst at Barclays, reiterates coverage on [InnovAge Holding (INNV)](in the Technology sector with a Hold rating and a price target of $5.00 (1 day ago). - Recent Price: $5.62 - Average Analyst Price Target: $5.00 (-11.03%) - Market Cap: $694.10M [TipRanks.com]( also reports that [InnovAge Holding](currently has 1 analysts offering 12-month price targets and the consensus is a Hold rating with an average price target is $5.00. The target pricing ranges from a high forecast of $5.00 down to a low forecast of $5.00. [InnovAge Holding (INNV)](’s last closing price was $5.62 which would put the average price target at $5.00. Here are 3rd party ratings for [INNV](: - TipRanks.com: Hold - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak sell - Zacks.com: Sell, Bottom 36% (159 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [These 2 Dividend Stocks Pay Every Week]( [bc82e8e3-d6f...](Are you still looking for consistent income in this near-zero interest rate environment? There is a better way. I just revealed the Holy Grail of dividend stocks - a safe, reliable and consistent stock that [pays dividends EVERY single week](- 52 times a year. It's simple: Buy the stock this Monday and you'll get your first dividend payout in your bank account this Thursday....and then every Thursday after for as long as you own the stock! [Tap here to reveal the name of this stock for FREE.]( [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- [Eve Holding, EVEX]( Recent Analyst Action: Marvin Fong, analyst at BTIG, reiterates coverage on [Eve Holding (EVEX)](in the Financial sector with a Hold rating (1 month ago). - Recent Price: $10.94 - Average Analyst Price Target: $7.30 (-33.27%) - Market Cap: $2.81B [TipRanks.com]( also reports that [Eve Holding](currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $7.30. The target pricing ranges from a high forecast of $7.30 down to a low forecast of $7.30. [Eve Holding (EVEX)](’s last closing price was $10.94 which would put the average price target at $7.30. Here are 3rd party ratings for [EVEX](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Sell, Top 40% (99 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- [Champions Oncology, CSBR]( Recent Analyst Action: Scott Henry, analyst at Roth Capital, reiterates coverage on [Champions Oncology (CSBR)](in the Healthcare sector with a Buy rating and a price target of $16.00 (1 month ago). - Recent Price: $8.92 - Average Analyst Price Target: $16.00 (79.37%) - Market Cap: $118.32M [TipRanks.com]( also reports that [Champions Oncology](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $16.00. The target pricing ranges from a high forecast of $16.00 down to a low forecast of $16.00. [Champions Oncology (CSBR)](’s last closing price was $8.92 which would put the average price target at $16.00. Here are 3rd party ratings for [CSBR](: - TipRanks.com: Moderate Buy - TradingView.com: Strong Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Strong buy - Zacks.com: Sell, Top 36% (90 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- Market Wizard who predicted all indexes would be negative in 2022 shares shocking new forecast: ["Prepare for Five Years of Famine"]( [Screen+Shot+...]( [Click here]( for the name of the one ticker you need to protect yourself.[5381a560-c43...]([aff_i?offer_...] --------------------------------------------------------------- [Grove Collaborative Holdings, GROV]( Recent Analyst Action: Dana Telsey, analyst at Telsey Advisory, reiterates coverage on [Grove Collaborative Holdings (GROV)](in the Financial sector with a Buy rating and a price target of $10.00 (2 months ago). - Recent Price: $6.7 - Average Analyst Price Target: $10.00 (49.25%) - Market Cap: $1.09B [TipRanks.com]( also reports that [Grove Collaborative Holdings](currently has 1 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $10.00. The target pricing ranges from a high forecast of $10.00 down to a low forecast of $10.00. [Grove Collaborative Holdings (GROV)](’s last closing price was $6.7 which would put the average price target at $10.00. Here are 3rd party ratings for [GROV](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: sell - Zacks.com: n/a, n/a [Click here for chart >>]( -------------------------------------------------------------------------- [Renaissancere Holdings, RNR]( Recent Analyst Action: Michael Phillips, analyst at Morgan Stanley, reiterates coverage on [Renaissancere Holdings (RNR)](in the Financial sector with a Hold rating and a price target of $150.00 (4 weeks ago). - Recent Price: $151.65 - Average Analyst Price Target: $171.80 (13.29%) - Market Cap: $6.64B [TipRanks.com]( also reports that [Renaissancere Holdings](currently has 6 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $171.80. The target pricing ranges from a high forecast of $210.00 down to a low forecast of $150.00. [Renaissancere Holdings (RNR)](’s last closing price was $151.65 which would put the average price target at $171.80. Here are 3rd party ratings for [RNR](: - TipRanks.com: Moderate Buy - TradingView.com: Buy - Yahoo! Finance: Bullish Short-Term Outlook - Barchart.com: Weak buy - Zacks.com: Hold, Bottom 42% (144 out of 251) [Click here for chart >>]( -------------------------------------------------------------------------- --------------------------------------------------------------- [Why is Russia reopening dormant copper mines?]( [b14984ed-650...](In deepest Siberia, Russian oligarchs are pouring $15 billion into two long-dormant copper mines with close access to the lucrative China market. Copper is essential to the West's plans to transition to green energy and Russia has the third-largest reserves in the world. Is Putin making a move to corner the copper market? New sources of copper – outside Russia – are desperately needed for the West to win its war for energy independence. [Here's where to look](//trailer.web-view.net/Links/0XF1C5901B727A22E59EE8CA646BA270DFC226B6BD17A31D2B540A9391F06A0F24304682727BC19AB74172733E16BFD56086F4752F34D7E0BB97B78C110EC8F65BF598CD369566B7DD.htm [5381a560-c43...]( [aff_i?offer_...] --------------------------------------------------------------- And there you have it--6 Five Day Gainers of all US Exchanges. Sincerely, The Editor, MarketMoversInsider.com Disclaimer This email/newsletter contains advertisements which are neither an offer nor recommendation to buy or sell any security. We hold no investment licenses and are thus neither licensed nor qualified to provide investment advice. The content in this email/newsletter is not provided to any individual with a view toward their individual circumstances. Compensation for advertising constitutes a conflict of interest as to our ability to remain objective in our communication regarding any companies profiled. Because of this conflict, individuals are strongly encouraged to not use this email/newsletter as the basis for any investment decision. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained in our email/newsletter is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between the any predictions and actual results. Always consult a real licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment. MarketMoversInsider.com part of Sandpiper Marketing Group, LLC 165 Lockerbie Lane | Mooresville | NC | 28115 MarketMoversInsider.com | 165 Lockerbie Lane | Moorsville | North Carolina | 28115 | United States | 8458030954 [Unsubscribe]( | [Report spam]( Sent with [ActiveTrail]( software